It has been previously shown by our group that IL-15, unlike other therapeutic cytokines such as IL-2 and IL-12, can stimulate expansion and activity of CD8 T cells and NK cells in vitro when they are exposed to prostate cancer cells (19). This evidence concerns the gene IL2 and prostate carcinoma.